MAVERICK THERAPEUTICS INC.

Profile

Company Names

MAVERICK THERAPEUTICS INC.

Addresses

3260B BAYSHORE BOULEVARD, BRISBANE, CA 94005

Phone Numbers

650-443-7400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$56,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2017-01-06 
$56,000,000.00 
$56,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
ARENDT 
DIRECTOR
MAVERICK THERAPEUTICS INC.
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
BARD 
 
GEESAMAN 
DIRECTOR
BIOSCALE INC   |  MAVERICK THERAPEUTICS INC.   |  REKINDLE THERAPEUTICS INC.   |  NBO PHARMA INC.
HANS PETER 
 
GERBER 
EXECUTIVE OFFICER, DIRECTOR
MAVERICK THERAPEUTICS INC.
DAN 
 
HICKLIN 
DIRECTOR
MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.
LORI 
 
KUNKEL 
DIRECTOR
TOCAGEN INC   |  MAVERICK THERAPEUTICS INC.   |  NURIX THERAPEUTICS, INC.   |  ORIC PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#